content_image/259067.jpg
The movement of property, plant and equipment for the year ended 31 March 2014 is as follows: 

<img src='content_image/259067.jpg'>

(Note) “Other” mainly includes exchange differences. 

The Group recognised impairment losses (or reversal of impairment losses) of ¥1,911 million for the year ended 31 March 2013 and ¥6,545 million for the year ended 31 March 2014, and they are mainly included in “Other expense” in the consolidated statements of income. 

Impairment losses (or reversal of impairment losses) of ¥1,911 million for the year ended 31 March 2013 mainly resulted from decisions to close the domestic training facilities in Atami, Shizuoka Prefecture, owned by a Japanese subsid- iary, and to dispose of machinery and vehicles owned by a U.S. subsidiary. The recoverable amount is calculated at the fair value less costs of disposal based on the appraisal value. The fair value of those assets was measured using the market approach where the calculation is based on the quoted prices 

of identical or similar assets in markets that are not active and categorised as Level 2 within the fair value hierarchy. Also, the recoverable amount of assets to be removed of is deemed to be zero. 

Impairment losses (or reversal of impairment losses) of ¥6,545 million for the year ended 31 March 2014 mainly resulted from decisions to transfer of the plant in Fuji, Shizuoka Prefecture, owned by a Japanese subsidiary to Nichi-Iko Pharmaceutical Co., Ltd., and to close the U.S. subsidiary due to the reshaping of the research framework. The recoverable amount of those assets owned by a Japanese subsidiary is calculated at the fair value based on the transfer agreement. The assets owned by a U.S. subsidiary are due to be disposal of and the recoverable amount is deemed to be zero. 

